Landscaping Tuberculosis Multimorbidity: Findings from a Cross-sectional Study in India

Overview

Journal BMC Public Health

Publisher Biomed Central

Specialty Public Health

Date 2024 Feb 13

PMID 38350875

Authors

A Chauhan

M Parmar

J D Rajesham

S Shukla

K C Sahoo

S Chauhan

S Chitiboyina

A Sinha

G Srigana

M Gorla

Sanghamitra Pati

Affiliations

Soon will be listed here.

Abstract

Background: Multimorbidity, the concurrent presence of two or more chronic conditions is an emerging public health challenge. Till date, most of the research have focused on the presence and interaction of selected co-morbidities in tuberculosis (TB). There exist a critical knowledge gap on the magnitude of multimorbidity among TB patients and its impact on health outcomes.

Methods: We undertook a cross-sectional study to assess the prevalence and patterns of multimorbidity among newly diagnosed TB patients in two states of India. A total of 323 patients were interviewed using a structured multimorbidity assessment questionnaire for primary care (MAQ-PC). MAQ-PC is already validated for Indian population and elicits 22 chronic conditions. We defined TB multimorbidity as the co-existence of TB with one or more chronic conditions and identified commonly occurring dyads (TB + single condition) and triads (TB + two conditions).

Results: More than half (52%) of TB patients reported multimorbidity. Among dyads, depression, diabetes mellitus (DM), acid peptic disease (APD), hypertension, chronic alcoholism, arthritis and chronic back ache (CBA) were the most common co-occurring conditions while 'DM + arthritis', 'depression + APD', 'depression + DM' were the most commonly occurring triads among TB patients. Factors such as increasing age, low levels of education, alcohol abusers, drug-resistant TB and having health insurance were significantly associated with multimorbidity among TB patients.

Conclusions: Our findings suggest high prevalence of multimorbidity among newly diagnosed TB patients in India. The presence of concordant and discordant conditions with TB may increase the health complexity, thus necessitating appropriate care protocols. Given, the current situation, wherein TB and non-communicable diseases (NCD) services are delivered through collaborative framework between programmes, there is a need for addressing multimorbidity at the healthcare delivery level.

Citing Articles

Prevalence and clinical profile of comorbidity among newly diagnosed pulmonary tuberculosis patients: a multi-center observational study in eastern China.

Wang W, Wang X, Chen S, Li J, Cheng Q, Zhang Y Front Med (Lausanne). 2025; 12:1446835.

PMID: 39935798 PMC: 11810726. DOI: 10.3389/fmed.2025.1446835.

Epidemiology and impact of chronic disease multimorbidity in India: a systematic review and meta-analysis.

Varanasi R, Sinha A, Bhatia M, Nayak D, Manchanda R, Janardhanan R J Multimorb Comorb. 2024; 14:26335565241258851.

PMID: 38846927 PMC: 11155324. DOI: 10.1177/26335565241258851.

References

Pati S, Swain S, Metsemakers J, Knottnerus J, van den Akker M . Pattern and severity of multimorbidity among patients attending primary care settings in Odisha, India. PLoS One. 2017; 12(9):e0183966. PMC: 5598947. DOI: 10.1371/journal.pone.0183966. View

Skou S, Mair F, Fortin M, Guthrie B, Nunes B, Miranda J . Multimorbidity. Nat Rev Dis Primers. 2022; 8(1):48. PMC: 7613517. DOI: 10.1038/s41572-022-00376-4. View

Stubbs B, Siddiqi K, Elsey H, Siddiqi N, Ma R, Romano E . Tuberculosis and Non-Communicable Disease Multimorbidity: An Analysis of the World Health Survey in 48 Low- and Middle-Income Countries. Int J Environ Res Public Health. 2021; 18(5). PMC: 7967573. DOI: 10.3390/ijerph18052439. View

Thakur G, Thakur S, Thakur H . Status and challenges for tuberculosis control in India - Stakeholders' perspective. Indian J Tuberc. 2021; 68(3):334-339. PMC: 7550054. DOI: 10.1016/j.ijtb.2020.10.001. View

Pati S, Hussain M, Swain S, Salisbury C, Metsemakers J, Knottnerus J . Development and Validation of a Questionnaire to Assess Multimorbidity in Primary Care: An Indian Experience. Biomed Res Int. 2016; 2016:6582487. PMC: 4761379. DOI: 10.1155/2016/6582487. View

Siddiqi K, Stubbs B, Lin Y, Elsey H, Siddiqi N . TB multimorbidity: a global health challenge demanding urgent attention. Int J Tuberc Lung Dis. 2021; 25(2):87-90. DOI: 10.5588/ijtld.20.0751. View

Reid M, Arinaminpathy N, Bloom A, Bloom B, Boehme C, Chaisson R . Building a tuberculosis-free world: The Lancet Commission on tuberculosis. Lancet. 2019; 393(10178):1331-1384. DOI: 10.1016/S0140-6736(19)30024-8. View

Jarde A, Romano E, Afaq S, Elsony A, Lin Y, Huque R . Prevalence and risks of tuberculosis multimorbidity in low-income and middle-income countries: a meta-review. BMJ Open. 2022; 12(9):e060906. PMC: 9528681. DOI: 10.1136/bmjopen-2022-060906. View

Eris Gulbay B, Gurkan O, Akkoca Yildiz O, Onen Z, Oner Erkekol F, Baccioglu A . Side effects due to primary antituberculosis drugs during the initial phase of therapy in 1149 hospitalized patients for tuberculosis. Respir Med. 2006; 100(10):1834-42. DOI: 10.1016/j.rmed.2006.01.014. View

10.

Prasad R, Singh A, Gupta N . Tuberculosis and COVID-19 in India: Challenges and opportunities. Lung India. 2020; 37(4):292-294. PMC: 7507925. DOI: 10.4103/lungindia.lungindia_260_20. View

11.

Sachdeva K, Parmar M, Rao R, Chauhan S, Shah V, Pirabu R . Paradigm shift in efforts to end TB by 2025. Indian J Tuberc. 2020; 67(4S):S48-S60. DOI: 10.1016/j.ijtb.2020.11.001. View

12.

Giri S, Sahu P, Kanungo S, Bal H, Kumar S, Kar S . Diabetes mellitus and human immunodeficiency virus (HIV) infection in people with tuberculosis in Odisha, India. Indian J Tuberc. 2024; 71(2):147-152. DOI: 10.1016/j.ijtb.2023.04.021. View

13.

Chen L, Bao D, Gu L, Gu Y, Zhou L, Gao Z . Co-infection with hepatitis B virus among tuberculosis patients is associated with poor outcomes during anti-tuberculosis treatment. BMC Infect Dis. 2018; 18(1):295. PMC: 6029116. DOI: 10.1186/s12879-018-3192-8. View

14.

Rodriguez-Takeuchi S, Renjifo M, Medina F . Extrapulmonary Tuberculosis: Pathophysiology and Imaging Findings. Radiographics. 2019; 39(7):2023-2037. DOI: 10.1148/rg.2019190109. View

15.

Chauhan A, Mahapatra S, Sinha R, Pati S . Practicing health promotion in primary care -a reflective enquiry. J Prev Med Hyg. 2018; 58(4):E288-E293. PMC: 5912790. DOI: 10.15167/2421-4248/jpmh2017.58.4.749. View

16.

Reis-Santos B, Gomes T, Macedo L, Horta B, Riley L, Maciel E . Prevalence and patterns of multimorbidity among tuberculosis patients in Brazil: a cross-sectional study. Int J Equity Health. 2013; 12:61. PMC: 3765118. DOI: 10.1186/1475-9276-12-61. View

17.

Peltzer K . Tuberculosis non-communicable disease comorbidity and multimorbidity in public primary care patients in South Africa. Afr J Prim Health Care Fam Med. 2018; 10(1):e1-e6. PMC: 5913762. DOI: 10.4102/phcfm.v10i1.1651. View

18.

Chen Q, Che Y, Xiao Y, Jiang F, Chen Y, Zhou J . Impact of Multimorbidity Subgroups on the Health Care Use and Clinical Outcomes of Patients With Tuberculosis: A Population-Based Cohort Analysis. Front Public Health. 2021; 9:756717. PMC: 8531479. DOI: 10.3389/fpubh.2021.756717. View

19.

Kroenke K, Spitzer R, Williams J . The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001; 16(9):606-13. PMC: 1495268. DOI: 10.1046/j.1525-1497.2001.016009606.x. View